share_log

Truist Securities Reiterates Hold on Quest Diagnostics, Maintains $145 Price Target

Moomoo 24/7 ·  Mar 20 11:52

Truist Securities analyst David Macdonald reiterates Quest Diagnostics (NYSE:DGX) with a Hold and maintains $145 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment